The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease
A key criterion for the most common chronic liver disease—non-alcoholic fatty liver disease (NAFLD)—is an intrahepatic fat content above 5% in individuals who are not using steatogenic agents or having significant alcohol intake. Subjects with NAFLD have increased plasma concentrations of glucagon,...
Main Author: | Katrine D. Galsgaard |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/12/4049 |
Similar Items
-
Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis
by: Marie Winther-Sørensen, et al.
Published: (2020-12-01) -
Glucagon Receptor Signaling and Glucagon Resistance
by: Lina Janah, et al.
Published: (2019-07-01) -
Glucagon Receptor Signaling and Lipid Metabolism
by: Katrine D. Galsgaard, et al.
Published: (2019-04-01) -
Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
by: Maria Corina Plaz Torres, et al.
Published: (2020-05-01) -
The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease
by: Laia Bertran, et al.
Published: (2021-05-01)